Examining the Magnitude of Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients

被引：0
|
作者：
Weinhandl, Eric D. [1 ,2 ]
Hwang, Yunji [3 ]
Gilbertson, David T. [1 ,2 ]
Petersen, Jeffrey [3 ]
机构：
[1] Chron Dis Res Grp, Minneapolis, MN USA
[2] Univ Minnesota Twin Cities, Minneapolis, MN USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO700
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [1] Erythropoiesis-stimulating agent hyporesponsiveness
    Johnson, David W.
    Pollock, Carol A.
    Macdougall, Iain C.
    NEPHROLOGY, 2007, 12 (04) : 321 - 330
  • [2] Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients
    Luo, Jiacong
    Jensen, Donna E.
    Maroni, Bradley J.
    Brunelli, Steven M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 68 (05) : 763 - 771
  • [3] Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
    Kalantar-Zadeh, Kamyar
    Lee, Grace H.
    Miller, Jessica E.
    Streja, Elani
    Jing, Jennie
    Robertson, John A.
    Kovesdy, Csaba P.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (05) : 823 - 834
  • [4] Inflammation and Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection
    Shah, Hitesh H.
    Uppal, Nupur N.
    Fishbane, Steven
    KIDNEY MEDICINE, 2020, 2 (03) : 245 - 247
  • [5] Erythropoiesis-stimulating agent hyporesponsiveness in dialysis patients: Be aware of subclinical hypothyroidism
    Su, Shih-Chieh
    Wu, Chia-Chao
    Chen, Chun-Chi
    NEPHROLOGY, 2013, 18 (06) : 478 - 478
  • [6] Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study
    Rieko Eriguchi
    Masatomo Taniguchi
    Toshiharu Ninomiya
    Hideki Hirakata
    Satoru Fujimi
    Kazuhiko Tsuruya
    Takanari Kitazono
    Journal of Nephrology, 2015, 28 : 217 - 225
  • [7] Erythropoiesis-stimulating agent hyporesponsiveness was associated with worse survival of hemodialysis patients independent of the serum ferritin level
    Hanafusa, Norio
    Henn, Lisa
    Bieber, Brian
    Hasegawa, Takeshi
    Usui, Tomoko
    Robinson, Bruce
    Karaboyas, Angelo
    Nangaku, Masaomi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2025, 29 (01) : 23 - 33
  • [8] Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study
    Eriguchi, Rieko
    Taniguchi, Masatomo
    Ninomiya, Toshiharu
    Hirakata, Hideki
    Fujimi, Satoru
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    JOURNAL OF NEPHROLOGY, 2015, 28 (02) : 217 - 225
  • [9] Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?
    Wish, Jay B.
    KIDNEY MEDICINE, 2020, 2 (05) : 526 - 528
  • [10] The Resection of Thyroid Cancer Was Associated with the Resolution of Hyporesponsiveness to an Erythropoiesis-stimulating Agent in a Hemodialysis Patient with Aceruloplasminemia
    Nagata, Soichiro
    Ikegaya, Naoki
    Ogino, Shuhei
    Uchida, Shinichi
    Itaya, Mikiko
    Momita, Aoi
    Shinozaki, Shingo
    Ohura, Masaharu
    Kuriki, Ken
    Kono, Satoshi
    Miyajima, Hiroaki
    Hishida, Akira
    INTERNAL MEDICINE, 2017, 56 (07) : 805 - 810
12345